We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Zinc Corrosion Behavior Favors Bioabsorbable Stents

By HospiMedica International staff writers
Posted on 26 Mar 2013
A new study proposes that Zinc be considered as the ideal biomaterial for use in bioabsorbable cardiac stents. More...


Researchers at Michigan Technological University (MTU; Houghton, USA) examined Zinc as a candidate for a bioabsorbable cardiac stent material since it is necessary in a myriad of biological processes, exhibits antiatherogenic properties, and possesses outstanding ductility. Besides serving as physiologically as a promoter of healthy vessels, it also combines the best behaviors of iron and magnesium (the current bioabsorbable stent materials), and could supplant them as the favored base metal for bioabsorbable cardiac stents.

To examine critical aspects of biocorrosion, the researchers cut Zinc wires of 99.99%+ purity into 15 mm segments, and smoothed them to avoid any burrs that would hinder implantation. The wires were also subject to UV illumination to eradicate organic contamination at the molecular level, and placed in the abdominal aorta of rats by puncturing the arterial adventitia. After a period of 1.5, 3, 4.5, or 6 months, the rats were euthanized and the wires were then harvested for analysis and the state of the artery documented during necropsy. To preserve any corrosion layer on the wires’ surfaces, the attached tissue was dehydrated by immersing the samples for a short time in absolute ethanol.

The results showed that the wires that remained in the biological milieu for 1.5 and 3 months showed signs of relatively uniform corrosion. The remaining metallic cores of both explants had ragged edges in cross section, which are posited to correspond to the removal of material by semi-localized dissolution. After 4.5 and 6 months in vivo, the shallow, evenly distributed features yielded to relatively severe, localized corrosion. In all cases, tissue adhered preferentially to points of localized attack. A limited amount of microscale corrosion particulate was firmly embedded in the still-attached arterial tissue surrounding the metallic zinc core. The study was published early online on March 14, 2013, in Advanced Materials.

“Metallic zinc appears to be one of the few physiologically acceptable metals that have not yet been considered for application in a bioabsorbable stent,” said lead author Jeremy Goldman, PhD, of the MTU department of biomedical engineering. “Zinc is widely acknowledged as an essential element for basic biological function, as it participates in nucleic acid metabolism, signal transduction, apoptosis regulation, and gene expression, in addition to interacting with a variety of organic ligands.”

The researchers also stressed that the toxic potential of a zinc stent should be negligible, since assuming complete degradation within one year of the stent, the expected daily dose of zinc would be 150 μg per day, which is just a fraction of the recommended daily value for infants, and a mere 4% of the recommended daily intake for adult males, making the systemic toxicity of a zinc stent nonexistent.

Related Links:
Michigan Technological University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.